What is HC Wainwright’s Estimate for MDGL Q1 Earnings?
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for shares of Madrigal Pharmaceuticals in a note issued to investors on Thursday, February 27th. HC Wainwright analyst E. Arce now forecasts that the biopharmaceutical company will post earnings of ($2.83) per share for the quarter, […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for shares of Madrigal Pharmaceuticals in a note issued to investors on Thursday, February 27th. HC Wainwright analyst E. Arce now forecasts that the biopharmaceutical company will post earnings of ($2.83) per share for the quarter, […]
